[go: up one dir, main page]

Wang et al., 2013 - Google Patents

1H-NMR based metabonomic profiling of human esophageal cancer tissue

Wang et al., 2013

View HTML @Full View
Document ID
15328762343272220891
Author
Wang L
Chen J
Chen L
Deng P
Bu Q
Xiang P
Li M
Lu W
Xu Y
Lin H
Wu T
Wang H
Hu J
Shao X
Cen X
Zhao Y
Publication year
Publication venue
Molecular cancer

External Links

Snippet

Background The biomarker identification of human esophageal cancer is critical for its early diagnosis and therapeutic approaches that will significantly improve patient survival. Specially, those that involves in progression of disease would be helpful to mechanism …
Continue reading at link.springer.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy
    • G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
    • G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance

Similar Documents

Publication Publication Date Title
Wang et al. 1H-NMR based metabonomic profiling of human esophageal cancer tissue
Wang et al. ¹H NMR-based metabolic profiling of human rectal cancer tissue
Wang et al. Tissue metabolic profiling of human gastric cancer assessed by 1H NMR
Cheung et al. The applications of metabolomics in the molecular diagnostics of cancer
Chen et al. Metabolomics study of oral cancers
Lin et al. 1H NMR‐based metabolomics reveal overlapping discriminatory metabolites and metabolic pathway disturbances between colorectal tumor tissues and fecal samples
Giskeødegård et al. Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia
Zhang et al. Non-targeted and targeted metabolomics approaches to diagnosing lung cancer and predicting patient prognosis
Zhong et al. Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations
Pérez-Rambla et al. Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia
Hao et al. Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment
Liu et al. LC-MS-based plasma metabolomics and lipidomics analyses for differential diagnosis of bladder cancer and renal cell carcinoma
Gao et al. Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues
Kumar et al. High‐resolution NMR spectroscopy of human body fluids and tissues in relation to prostate cancer
Oakman et al. Uncovering the metabolomic fingerprint of breast cancer
Chen et al. Metabolomics: a promising diagnostic and therapeutic implement for breast cancer
Chan et al. Metabonomic profiling of bladder cancer
Shang et al. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy
Vermathen et al. 1H HR-MAS NMR based metabolic profiling of cells in response to treatment with a hexacationic ruthenium metallaprism as potential anticancer drug
Tan et al. Three serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer
Silva et al. Untargeted urinary 1H NMR-based metabolomic pattern as a potential platform in breast cancer detection
O ‘Connell Recent advances in metabolomics in oncology
Ma et al. Metabolomics in the fields of oncology: a review of recent research
Franko et al. Human prostate cancer is characterized by an increase in urea cycle metabolites
Kim et al. Potential metabolomic biomarkers for evaluation of adriamycin efficacy using a urinary 1H‐NMR spectroscopy